Journal article
Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem
SJ Rogerson, M Desai, A Mayor, E Sicuri, SM Taylor, AM van Eijk
Lancet Infectious Diseases | ELSEVIER SCI LTD | Published : 2018
Abstract
Over the past 10 years, knowledge of the burden, economic costs, and consequences of malaria in pregnancy has improved, and the prevalence of malaria caused by Plasmodium falciparum has declined substantially in some geographical areas. In particular, studies outside of Africa have increased the evidence base of Plasmodium vivax in pregnancy. Rapid diagnostic tests have been poor at detecting malaria in pregnant women, while PCR has shown a high prevalence of low density infection, the clinical importance of which is unknown. Erythrocytes infected with P falciparum that express the surface protein VAR2CSA accumulate in the placenta, and VAR2CSA is an important target of protective immunity. ..
View full abstractGrants
Funding Acknowledgements
This publication is supported and endorsed by the MiP Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. We thank Azucena Bardaji (ISGlobal, Barcelona) and Steven Meshnick (University of North Carolina) for their helpful reviews of the manuscript, and Kara Hanson (London School of Hygiene & Tropical Medicine) for advice on the health economic aspects of the burden of malaria in pregnancy.